Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride effects on esophageal function in healthy volunteers
NL-OMON24265Active, not recruiting
- Sponsor
- AMC Health
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of prucalopride in gastroesophageal reflux disease (GERD), functional dyspepsia (FD) and gastroparesis (2 arms), sponsored by AMC Health. Primary endpoint: Number of esophageal reflux episodes during the 24-hour study. Started Jun 2011; status: active, not recruiting.
02
Drugs
prucalopride
03
Conditions
gastroesophageal reflux disease (GERD)functional dyspepsia (FD)gastroparesis
Beyond the preview
Go deeper on NL-OMON24265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24265.